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Abstract
Objective—We demonstrate the feasibility of implementing a referral and management system for
cryotherapy-ineligible women in a “screen-and-treat” cervical cancer prevention program targeting
HIV-infected women in Zambia.
Methods—We established criteria for patient referral, developed a training program for loop
electrosurgical excision procedure (LEEP) providers, and adapted LEEP to a resource-constrained
setting.
Results—We successfully trained 15 nurses to perform visual inspection with acetic acid (VIA)
followed by immediate cryotherapy. Women with positive tests but ineligible for cryotherapy were
referred for further evaluation. We trained four Zambian physicians to evaluate referrals, perform
punch biopsy, LEEP, and manage intra-operative and post-operative complications. From January
2006 through October 2007, a total of 8823 women (41.5% HIV seropositive) were evaluated by
nurses in outlying prevention clinics; of these, 1477 (16.7%) were referred for physician evaluation
based on established criteria. Of the 875 (59.2% of 1147 referred) that presented for evaluation, 748
(8.4% of total screened) underwent histologic evaluation in the form of punch biopsy or LEEP.
Complications associated with LEEP included anesthesia reaction (n=2) which spontaneously
resolved, intra-operative (n=12) and post-operative (n=2) bleeding managed by local measures, and
post-operative infection (n=12) managed with antibiotics.
Conclusion—With adaptations for a resource-constrained environment, we have demonstrated that
performing LEEP is feasible and safe, with low rates of complications that can be managed locally.
It is important to establish referral and management systems using LEEP-based excisional evaluation
for women with cryotherapy-ineligible lesions in VIA-based “screen-and-treat” protocols nested
within HIV-care programs in resource-constrained settings.
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Introduction
Invasive cervical cancer is a preventable disease diagnosed in 493,000 women and resulting
in 274,000 deaths worldwide each year [1]. Greater than 20% of the world's annual deaths from
cervical cancer occur in sub-Saharan African countries, like Zambia, where cervical cancer is
the most common malignancy and the leading cause of cancer-related deaths among women
[1,2]. Limited or non-existent resources for screening and treatment of precancerous lesions
result in the vast majority of women presenting with incurable disease at the time of diagnosis
[2].
Human papillomavirus (HPV) is more prevalent among HIV-infected women and co-infection
with HPV and HIV leads to higher and more rapid progression rates of cervical intraepithelial
neoplasia (CIN), the precursor to cervical cancer [3]. Increasing numbers of HIV-infected
women in resource-constrained nations are gaining access to antiretroviral therapy (ART) [4,
5]. This may lead to increasing life expectancy, higher cumulative risk for persistent oncogenic
HPV infections and subsequent development of CIN [6,7]. A significant proportion of HIV-
infected women seeking antiretroviral therapy (ART) in Zambia harbor high-risk HPV-
infection and CIN at baseline; thus it is critical to provide frequent screening and appropriate
treatment services to these women to lower their risk of developing invasive cervical cancer
[8,9].
Single-visit “screen-and-treat” programs using visual inspection with acetic acid (VIA) linked
to cryotherapy have been shown to be effective methods of cervical cancer prevention in
resource-constrained settings [10–12]. We recently established Zambia's first VIA-based
cervical cancer prevention program, implemented as a routine healthcare service for women
attending government-operated health clinics [13,14]. Building upon an existing HIV-care and
treatment infrastructure, we targeted service provision to HIV-infected women who were
accessing antiretroviral therapy and HIV care through a President's Emergency Plan for AIDS
Relief (PEPFAR)-funded program [15]. Trained nurses served as primary health care providers
and performed VIA and cryotherapy, while referring women with cryotherapy-ineligible
lesions to a central, university hospital-based clinic. At the referral clinic, trained physicians
performed punch biopsy and/or loop electrosurgical excision procedure (LEEP), an office-
based surgical technique shown to be safe and effective for the management of precancerous
cervical lesions (cervical intraepithelial neoplasia—CIN) [16]. This paper describes the
feasibility and operationalization of providing referral and management services, inclusive of
LEEP-based excisional evaluation, within a cervical cancer prevention program targeting HIV
seropositive women in a resource-constrained sub-Saharan African nation.
Materials and methods
From January 2006 to October 2007, we implemented VIA-based “screen-and-treat” cervical
cancer prevention services in 13 outlying primary care government-operated clinics and a
tertiary care hospital in Lusaka, Zambia. We describe the steps taken to effectively implement
the referral and management system for cryotherapy-ineligible women needing further
evaluation.
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Zambian Cervical Cancer Prevention Program clinics have been developed within the context
of an HIV-care and treatment program supported through PEPFAR. Given the high risk of
cervical precancer and cancer in HIV-infected women in Zambia[8], we undertake the
following focused activities for enrolling HIV-infected women: first, we train HIV peer
educators (lay health workers) to deliver messages in the community about the importance of
cervical cancer screening in HIV-infected women as they sensitize women to be tested for
HIV. Second, cervical cancer peer educators (lay health workers) give daily cervical cancer
prevention talks in the HIV-care and treatment clinics in each of the facilities where our cervical
cancer prevention services are offered. Third, cervical cancer peer educators navigate HIV-
infected women who are interested in being screened into cervical cancer prevention clinics.
Fourth, staff members in the HIV-care and treatment clinics are strongly encouraged to refer
every HIV-infected woman to the clinics to be screened for cervical cancer. And fifth our nurses
educate patients about the high risk of cervical cancer in HIV-infected women and are trained
DCT (diagnostic counseling and testing for HIV) counselors.
Establishing a referral system
Following VIA-based “screen-and-treat” protocol, nurses performed immediate cryotherapy
and effectively referred patients requiring further evaluation [17]. Referral reasons included
visual characteristics that are predictive of extensive high-grade disease or invasion or
abnormalities that precluded successful cryotherapy [18]. See Table 1. Women requiring
referral were given an appointment at the tertiary care hospital, University Teaching Hospital
(UTH), within 1–2 weeks. In evaluating referred patients, physicians repeated VIA and
reviewed nurse referral reasons. Physicians performed punch biopsy or LEEP when indicated.
Women with clinically invasive cancer assessed to be at risk for hemorrhage following punch
biopsy were referred to another setting within UTH better prepared to manage such events.
Patients with other complaints and gynecologic disorders unrelated to a positive VIA test were
referred to the appropriate gynecologic services at the University Teaching Hospital.
Training of physicians to perform LEEP
Because LEEP was not previously available in Zambia, we instituted a comprehensive training
curriculum for physicians at UTH (Fig. 1). We developed a four-step plan that included didactic
sessions and practical training. Physician-trainees first familiarized themselves with the
equipment using simulated models [19]. They observed 10 LEEP procedures performed by
experienced gynecologists (GP and MM), performed 25 procedures under close supervision
of experienced gynecologists, then performed 25 additional procedures with the experienced
gynecologist in close proximity. Once the trainee appropriately performed a total of 50 LEEPs,
he/she was certified to have completed training and eligible to practice independently. In our
program the process was usually completed within 4 weeks, after which time the trainee
received a certificate of competency in LEEP provision and management of complications.
Adapting LEEP to a resource-constrained environment
We encountered numerous challenges to implementing routine and reliable LEEP services in
this resource-constrained setting. In Table 2, we list several of these barriers as well as the local
solutions devised to address them.
Pathology
Tissue specimens were reviewed in Zambia by a United Kingdom-trained, board-certified
Zambian senior pathologist (VM) in the Pathology department of UTH.
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Women were asked to return to the Gynecologic Cancer Prevention Unit for pathology results
and follow-up 6 weeks after punch biopsy or LEEP. Gynecologic complaints prompted pelvic
examination. Women with preinvasive cancer received appointments for six- and 12-month
post-LEEP repeat VIA examination in the clinics from which they were referred. Those with
stages IA1 to IB2 were referred to the Gynecology department at UTH for appropriate surgery
and those with >stage IIA were referred to the newly established Cancer Disease Hospital
within UTH for radiation therapy or palliative care.
Results
Integration in pre-existing infrastructures
One of the keys to sustainability of a new program is integration into pre-existing
infrastructures. Towards this end we placed our screening and LEEP program at government-
operated health facilities. One of the program co-directors (MM) is a full-time university-based
Zambian gynecologist; the other program co-director (GP) is a U.S. trained and board-certified
gynecologic oncologist and citizen but has received a full-time appointment as Honorary
Professor in the Department of Obstetrics and Gynecology at the same university. The
University Senate recently approved an application for the Cervical Cancer Prevention
Program to become an official rotation for Zambian medical students and Obstetrics and
Gynecology residents/registrars as part of their formal medical training. The Ministry of Health
has signed off on the development of a curriculum that would lead to a Cervical Cancer
Prevention Nurse Certificate, on par with Maternal Child Health, Nurse Midwifery, etc.
Referral for LEEP
Since the initial roll-out of our “screen-and-treat” program in January 2006 until October 2007,
we screened a total of 8823 women. These include 3661 (41.5%) who were HIV-infected (HIV
seropositive), 2534 (28.7%) HIV seronegative, and 2628 (29.8%) of unknown HIV serostatus.
HIV-infected women have access to ART through the PEPFAR-supported HIV-care and
treatment program in the Lusaka District Health Management clinics if they meet World Health
Organization laboratory and clinical criteria. Among our HIV-infected patients, 69.3% had
documented use of ART. A total of 2378 (26.9%) women were treated with cryotherapy for
positive VIA tests while 1477 (16.7%) were referred for physician evaluation. Despite a lack
of any formal patient tracking system, 875 women (59.2% of those referred) kept their
appointments for a physician evaluation at the Gynecologic Cancer Prevention Unit at the
University Teaching Hospital. Physician evaluation revealed 106 women with gynecologic
conditions that did not require histological evaluation of the cervix and 21 women with
clinically evident invasive cervical cancer who were assessed to be at risk for hemorrhage
following punch biopsy and thus referred to another setting within UTH better prepared to
manage such events. 748 women (8.4% of total women screened) underwent LEEP. These
included 465 (62.2%) who were HIV-infected, 116 (15.5%) who were HIV seronegative and
167 (22.3%) whose HIV serostatus was unknown at the time of screening.
Intra-operative and post-operative complications
Complications commonly cited for LEEP are peri-operative/intra-operative bleeding, post-
operative bleeding, cervical infection and cervical stenosis [18]. Intra-operative bleeding is
described as bleeding that requires vaginal packing or suturing for hemostasis. Mild to
moderate post-operative bleeding is defined as bleeding that prompts a return visit to the clinic
requiring re-cauterization or application of Monsel's solution, while severe post-operative
bleeding is defined as bleeding that requires hospital admission, blood transfusion or suturing.
Two women experienced uncontrollable trembling of the lower extremities after the cervical
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injection of 2% lidocaine with 1:80,000 epinephrine which spontaneously resolved in 5 min.
Twelve women who underwent LEEP experienced intra-operative bleeding and 2 experienced
post-operative bleeding that prompted a return visit to the clinic. None required blood
transfusions or intravenous fluids and all were managed successfully with local measures in
the clinic, on an outpatient basis. Of the 12 women who experienced intra-operative bleeding
uncontrolled by cautery, 10 had arterial bleeders at the surgical site and 2 had incidental vaginal
sidewall lacerations. Cervical arterial bleeding was controlled by the local application of a
hemostatic agent (Monsel's solution) coupled with vaginal packing in 3 patients and suturing
in the remaining 7 patients. Patients treated with vaginal packing were asked to lie still on a
clinic bench for 2 h after which time the pack was removed and they were discharged home.
The 2 cases of bleeding secondary to vaginal lacerations were controlled by suturing. No
anesthesia was required in any of the cases requiring suturing. Two women had excessive
bleeding from the surgical site 24 h post-excision, requiring an application of Monsel's solution
to the cervix and immediate discharge from the clinic. None of our patients experienced severe
post-operative bleeding. Twelve women returned with vaginal discharge consistent with a post-
operative surgical site infection, for which antibiotics were prescribed and the condition
resolved. None of our patients reported complaints consistent with cervical stenosis.
Complications by HIV serostatus are listed in Table 3.
Pathology
Among women who underwent histologic evaluation, 155 had CIN I, 144 had CIN II/III, and
149 had invasive cancer (58% microinvasive). Disease prevalence according to HIV serostatus
is presented in Table 4.
Discussion
We established a referral and management system for women screened and treated by nurses
in a single-visit “screen-and-treat” cervical cancer prevention program targeting HIV-infected
women in a resource-constrained setting in Zambia. By establishing criteria for referral,
training physicians to perform LEEP, and adapting LEEP to the environmental context, we
successfully operationalized the program. Referral criteria enabled nurses to triage patients for
immediate cryotherapy or referral for physician evaluation. Our LEEP training program
produced four physicians with a high degree of skill in both performing the procedure and
managing complications. Based on our case volume the training was completed within 4 weeks.
Complications included intra-operative and post-operative bleeding managed effectively by
local measures (vaginal packing, application of a haemostatic agent or suturing), self-limited
anesthesia reaction, and post-operative infections that resolved with antibiotic treatment. Since
the overall rate of complications was very low, the sample size was not adequate to allow us
to compare for any significant difference in complications between HIV seropositive and HIV
seronegative patients. Although our intra-operative complication rate is minimal and
substantially documented, it is possible that post-operative complication rates are under-
reported due to low patient compliance, despite our efforts to emphasize to patients and
accompanying family members the importance of adhering to the prescribed post-surgical
follow-up regimen. During normal working hours, patients have access to the Gynecologic
Cancer Prevention Unit as well as the clinics from which they were referred, where the nurses
have been trained to recognize, treat, and document post-operative complications. UTH is open
24 h a day and is 2–3 miles away from the communities surrounding the referral clinics with
bus routes to the hospital. Studies of LEEP in HIV-infected women in high resource settings
report comparable safety profiles [20]. Little has been documented regarding complications
following ablational and excisional therapies for CIN in low resource nations, particularly
among HIV-infected women. In a small study of 72 women in Zimbabwe, Chirenje et al.
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reported a 12-month cure rate of 86% in HIV-infected women compared to 100% in HIV
seronegative women but did not discuss complications [21]. In a study of 60 HIV-infected
women receiving LEEP in Thailand, no significant difference in complications could be
demonstrated between HIV-infected women and the control group nor between HIV-infected
women receiving antiretroviral therapy and those not receiving antiretroviral therapy [22]. We
confirm the safety profile of LEEP in HIV-infected women in a resource-constrained setting
with the largest such cohort reported based on our review of the English language medical
literature. Despite encountering barriers common to low resource nations (see Table 2) we
established LEEP services to effectively fulfill second tier needs of a VIA-based “screen-and-
treat” cervical cancer prevention program. The provision of these services fills the gap between
cryotherapy treatment and inpatient diagnostic/therapeutic procedures (conization,
hysterectomy).
Major limitations to the sustainability and effectiveness of a LEEP program in a resource-
constrained nation include limited availability of certain medical supplies, low patient follow-
up, the cost to participants, and demands on pathology services. LEEP maintenance and
replacement parts are unavailable within Zambia, requiring constant outsourcing. We are
working to develop a more effective patient follow-up system as only 59.2% of women referred
actually presented for evaluation. Reasons most often given for not presenting for evaluation
include (1) difficulty getting partner support for post-treatment sexual abstinence (6 weeks),
(2) fear of the procedure itself, and (3) travel costs to reach the hospital from outlying areas.
As a service delivery program, we cannot offer incentives to patients to present for physician
evaluation or to comply with prescribed post-surgical follow-up. However, we do not charge
any fees to perform biopsy or LEEP and the UTH Pathology department charges only 5000
Zambian Kwacha (about US $1.40) to process and analyze tissue specimens. The cost of public
transportation to reach UTH and return home from even the furthest areas of referral in Lusaka
is 10,000 Zambian Kwacha (about US $2.80) or less. A successful referral and management
program requires adequate pathology personnel and supplies. Historically, health care staff
with these specialized pathology skills have been difficult to retain in Zambia (Personal
communication, Victor Mudenda, MD). The overwhelming case burden and severe shortage
of trained staff in the Pathology department have made it impossible to comment on margin
status. Given the long time period that it takes to train pathologists, and their persistent brain
drain once trained, we have begun exploring the possibility of establishing a digital pathology
center within the UTH Department of Pathology to allow for automated bulk processing, faster
interpretation of the tissue specimens and ability to report margin status. This system will also
allow for distance consultation (telepathology) and improve overall quality of cervical cancer
pathology as well as other pathology services at UTH by immediately increasing pathology
manpower without the necessity of on-site presence.
The outcomes of our program emphasize the need for operations and implementation research
in the following areas: (1) digital pathology to improve accuracy and efficiency of
histopathology services and (2) interventions to increase patient adherence to follow-up
recommendations. We plan to implement an appointment reminder system where patients
receive a text message reminding them of their appointment the day before it is scheduled. We
will call patients who miss appointments in order to reschedule. If the text message and phone
call fail or patients do not have access to a phone, lay health workers will follow-up in person
at the patient's home. Programmatic implications include a need to expand LEEP training to
include nurses and allied healthcare personnel (e.g., physicians' assistants), increase training
and interest among medical students and residents and creation of a national cervical cancer
prevention strategy.
Increasing attention and resources are being targeted for implementing cervical cancer
screening programs in the context of HIV-care programs in Africa and other resource-
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constrained settings. We are undertaking a cost effectiveness analysis of our program to provide
additional information to others who plan to establish critically important referral centers for
cryotherapy-ineligible women in resource-constrained environments like Zambia. Our
experience, one of few in a real-world program setting, has highlighted the role of gynecologic
evaluation and linked pathological diagnosis for lesions not treatable by cryotherapy and the
need for inclusion of these components in a comprehensive cervical cancer prevention program
for resource-constrained settings.
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Table 1
Ineligibility criteria for cryotherapy
Incomplete visualization of acetowhite lesion
Acetowhite lesion occupying ≥3 quadrants or ≥75% of the transformation zone
Acetowhite lesion unable to be entirely covered by the tip of the cryoprobe
Presence of a cervical lesion (e.g. polyp) or anatomic defect (e.g. scarring or fibrosis) that prevents flush contact between acetowhite lesion/transformation
zone and the cryoprobe
Suspicious of cancer
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Table 2
Common challenges and simple solutions for managing a loop electrosurgical excision procedure clinic in a resource-
constrained setting
Challenge Solution
Cervicitis/vaginitis at time of evaluation Low grade infection: concomitant treatment of infection a and cervical lesion.
High-grade infection (copious yellow discharge or upper abdominal symptoms/signs): treat
infection a first and give appointment date for LEEP in 2 weeks.
Voltage mismatch Step-down unit to adjust voltage to in-country requirements.
Voltage irregularities Voltage regulator to filter incoming current to stable outgoing current.
Inadequate hemostatic equipment Use ferric subsulfate solution and manual pressure when interruption of electrical current results
in inability to cauterize. Keep suture kit on hand in case of emergency. In the absence of a proper
needle driver use sponge forceps or any type of available clamp as needle holder.
Water shortage Keep 10–20 l of clean water in the clinic as a reserve for when water supply is interrupted.
Waste disposal Coordinate with hospital biohazardous waste disposal. If that fails, find a non-government
organization (NGO) partner to create regular collection times and consider building an incinerator.
Trained assistants Train a layperson to sterilize equipment, autoclaves, prepare exam room, give health talks, and
assist LEEPs.
Take care to explain special instructions for insulated speculums. If same sterilization techniques
for non-insulated speculums are used for insulated speculums, they will be destroyed after one or
two uses.
Non-availability of cervical needles,
syringes, and anesthetic
Consult local dentists as dental needles, syringes and anesthetic can be used for cervical anesthesia.
Inadequate pathology services Investigate local laboratory capacity, as it may not meet increased demands created by the LEEP
program.
• May need to assist by providing tissue processing supplies.
• Pathologist should be made aware of the significance of reporting LEEP specimen
margins.
• Ensure an adequate number of cuts through tissue block.
• Digital pathology may remove manpower shortage by allowing distance consultation.
Explain expected time delay for histopathology results to clients.
Timely delivery of supplies Develop a forecasting, delivery and storage system. Take into account supply shortages, driver/
vehicle requirements for transport, and time lag between ordering and receiving supplies.
Out of country supply orders For equipment purchased outside the country, shipment should include a very specific, itemized
listing of package contents (order number, quantity, shipping codes and any other information) to
identify and track equipment.
Equipment cost Sterilize and reuse electrodes by cleaning in soapy water followed by 10 min of decontamination
in 0.5% chlorine solution, water rinse, and 30 min autoclaving. Use regular needles rather than
specialty (Potocky™) needles.
a
Cervicitis and vaginitis treated in accordance with WHO syndromic treatment guidelines.
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Table 3
Intra- and post-operative complications







Anesthetic reaction 1 (0.002%) 0 (0%) 1 (0.006%)
Intra-operative bleeding a 6 (0.012%) 3 (0.025%) 3 (0.018%)
Post-operative
Mild to moderate post-operative
bleeding b
1 (0.002%) 0 (0%) 1 (0.006%)
Cervical infection 4 (0.008%) 6 (0.05%) 2 (0.012%)
Note: percentages denote cell proportions within total of each column, i.e. HIV serostatus.
a
Defined as bleeding that requires suturing or vaginal packing for hemostasis.
b
Defined as bleeding that prompts a return visit to clinic and requires re-cauterization or application of Monsel's solution.
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Table 4
Disease prevalence according to HIV serostatus
Pathologic diagnosis Overall Proportion of pathologic diagnoses by HIV serostatus
HIV seropositive HIV seronegative Unknown HIV serostatus
CIN I 155 63% 21% 16%
CIN II/III 144 74% 15% 11%
Invasive cancer 149 60% 27% 13%
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